Side-by-side comparison of AI visibility scores, market position, and capabilities
Camden NJ diversified food company (NYSE: CPB) at $10.3B FY2025 sales; rebranded to The Campbell's Company (Nov 2024), Rao's acquisition $2.7B, new CEO Mick Beekhuizen (Feb 2025) competing with General Mills for shelf-stable meals.
The Campbell's Company is a Camden, New Jersey-based diversified food manufacturer — publicly traded on the New York Stock Exchange (NYSE: CPB) as an S&P 500 Consumer Staples component — producing and marketing soups, snacks, sauces, and beverages under iconic consumer brands through approximately 14,000 employees with fiscal year 2025 net sales of $10.3 billion. Founded in 1869 by Joseph Campbell and Abraham Anderson as a fruit and vegetable canning operation, Campbell's became a cultural icon through chemist John T. Dorrance's 1897 condensed soup innovation. The company rebranded from Campbell Soup Company to The Campbell's Company in November 2024 (shareholder-approved) to signal its evolution beyond soup into a diversified food portfolio. Mick Beekhuizen became the 15th CEO in company history on February 1, 2025, succeeding Mark Clouse who retired to become President of the NFL's Washington Commanders. Beekhuizen joined Campbell's in 2019 as CFO and was elevated to President of Meals & Beverages in 2022. The company's $2.7 billion acquisition of Sovos Brands in 2024 added Rao's premium pasta sauce (the highest-rated mass-market pasta sauce brand), Michael Angelo's Italian meals, and noosa yogurt to the portfolio.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.